Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,065.61. The company's market cap stands at 1.01T, with a P/E ratio of 51.51 and a dividend yield of 57.6%.
On 2026-01-06, Eli Lilly(LLY) stock moved within a range of $1,040.00 to $1,070.83. With shares now at $1,065.61, the stock is trading +2.5% above its intraday low and -0.5% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 2.69M, versus its average volume of 2.36M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,111.99 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,111.99 and a low of $623.78.
LLY News
(RTTNews) - Shares of Ventyx Biosciences, Inc. (VTYX) surged more than 62% in after-hours trading on Tuesday after The Wall Street Journal reported that the com...
Equity futures were mixed after the major averages closed broadly higher for the second day in a row. Despite the strong start to the first trading week of 2026...
Technology Ventyx Biosciences Launches On Rumored $1 Billion Eli Lilly Takeover Licensing Shares of Ventyx Biosciences (VTYX) launched late Tuesday on reports E...
Analyst ratings
80%
of 30 ratingsMore LLY News
UBS assumed coverage of Biogen (BIIB) with a Neutral rating with a price target of $185, up from $130. The firm sees the competitor Eli Lilly’s (LLY) Phase III...
Eli Lilly (LLY) is in advanced talks to acquire Ventyx Biosciences (VTYX) or more than $1B, Lauren Thomas, Jonathan Rockoff and Ben Glickman of Wall Street Jour...
Eli Lilly’s talks are in the advanced stages. Mike Blake/Reuters Eli Lilly LLY 1.84 %increase; green up pointing triangle is in advanced talks to acquire Venty...
...
Nimbus Therapeutics announced it has entered into a multi-year research collaboration and exclusive, worldwide license agreement with Eli Lilly (LLY) and Compan...
Biotech and Pharma Zepbound Boost Gets a Lift From Arrowhead’s Drug. The Question Is Whether Patients Will Pay. In this article ARWR LLY WVE NOVO.B Arrowhead’s...
Research Google Stock, Lilly And An Aviation Name Are Fund Managers' Favorites Licensing IBD SwingTrader name Alphabet (GOOGL) and IBD 50 watchlist stock Eli Li...
